Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene - MarketLine Financial Deals

Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene

Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene - MarketLine Financial Deals
Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene
Published Oct 01, 2008
2 pages — Published Oct 01, 2008
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Panacea Biotec, Ltd., an India-based manufacturer and marketer of branded vaccines, pharmaceuticals, and biotechnology-based products, through its subsidiary, Kelisia Holdings, Ltd., has agreed to acquire a 19.9% stake in PharmAthene, Inc., a US-based developer of medical products against biological and chemical threats.

  
Source:
Document ID
MA00153_081003
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene" Oct 01, 2008. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Kelisia-Holdings-Panacea-Biotec-to-acquire-19-9-stake-in-PharmAthene-2052-106>
  
APA:
MarketLine Financial Deals. (2008). Kelisia Holdings (Panacea Biotec) to acquire 19.9% stake in PharmAthene Oct 01, 2008. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Kelisia-Holdings-Panacea-Biotec-to-acquire-19-9-stake-in-PharmAthene-2052-106>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.